Organizing Committee

Nissim Benvenisty, MD, PhD
The Hebrew University of Jerusalem, Israel

Robert Blelloch, MD, PhD
University of California, San Francisco, USA

Daniel Marshak, PhD
Consulting & Advisory, USA

Melissa Carpenter, PhD
ElevateBio, USA

Assem Ziady, PhD
Cincinnati Children’s Hospital Medical Center, USA

John Tisdale, MD

Shen Shen, PhD
Vertex Pharmaceuticals, USA

Gerhard Bauer, Professor
University of California, School of Medicine, USA

IS Madison 1000x220_2

ISSCR/ASGCT 2022 Madison International Symposium

The International Society for Stem Cell Research (ISSCR) and the American Society for Gene and Cell Therapy (ASGCT) are partnering to host an exciting program on the latest advancements in regenerative medicine at the intersection of genetic and cellular technologies. 

The marriage of genomic and cellular advances holds tremendous potential for regenerative medicine.  Recent discoveries in stem cell biology are being combined with powerful new gene-editing technologies to bring about potentially transformative new therapies for diseases affecting a wide range of tissue and organ systems. This three day meeting will highlight groundbreaking work developing therapies for diseases of the nervous, hematopoietic, and muscle systems, diabetes, metabolic diseases, and cancer, and feature forward-looking new technologies shaping the future of the field. 

Join us on 21 - 23 September 2022 when world-renowned scientists developing gene and cell therapies will converge in Madison, WI, a city recognized for its seminal contributions to human stem cell research, to present new discoveries at the leading edge of regenerative medicine. Sign up to receive emails about this event.

Keynote Speakers

Don Kohn 500x500
Donald Kohn, MD
Leslie Thompson, PhD
UC Irvine, USA

Speakers & Topics

Diabetes & Metabolic Diseases
Chris Mason, MD, PhD, AVROBIO, USA
Doug Melton, PhD, Harvard University, USA

Hematopoietic Diseases
Boro Dropulić, PhD, MBA, Caring Cross, USA
Tsvee Lapidot, PhD, Weizmann Institute of Science, Israel
Igor I. Slukvin, MD, PhD, University of Wisconsin-Madison, USA

In Utero Cell and Gene Therapy
Tippi Mackenzie, MD, UCSF Benioff Children's Hospital, USA
Charlotte Sumner, MD, Johns Hopkins University, USA

Central Nervous System Diseases
Malin Parmar, PhD, Lund University, Sweden
Catherine Priest, PhD, Neurona Therapeutics, USA

Muscle Disorders 
Christine Mummery, PhD, Leiden University, The Netherlands
Seng Cheng, PhD, Pfizer, USA

Cell & Gene Therapy Manufacturing 
Melissa Carpenter, PhD, ElevetaeBio, USA
David Dismuke, PhD, Forge Biologics, USA

Visual System
Michele De Luca, MD, University of Modena and Reggio Emilia, Italy
Sally Temple, PhD, Neural Stem Cell Institute, USA

Immuno-Oncology: CAR-T and NK cell therapies
Michel Sadelain, MD, PhD, Memorial Sloan Kettering Cancer Center, USA
Bob Valamehr, PhD, Fate Therapeutics, USA

New Technologies and Future Directions 
Shuibing Chen, PhD, Weill Cornell Medical College, USA
Viviana Gradinaru, PhD, California Institute for Technology, USA
Rubina Parmar, PhD, Intellia Therapeutics, USA